NCT00078975 2018-09-14
3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer
University Health Network, Toronto
Phase 2 Completed
Clinical Trials
3 trialsNCT00085371 2013-10-08
Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas
National Cancer Institute (NCI)
Phase 2 Completed
NCT00064051 2013-08-02
3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
National Cancer Institute (NCI)
Phase 2 Completed